AI in Endoscopy Market - By Type of Endoscopy, By Component, By Type of CAD, By End Use – Global Forecast 2025 – 2034

 AI in Endoscopy Market Size

The global AI in endoscopy market was estimated at USD 2.2 billion in 2024. The market is expected to grow from USD 2.8 billion in 2025 to USD 21.1 billion in 2034, at a CAGR of 25.3% during the forecast period. The increasing incidences of gastrointestinal disorders are driving market growth.
 

According to the World Gastroenterology Organization report, colorectal cancer is the third most common cancer globally, with over 1.9 million new cases annually. Similarly, inflammatory bowel diseases affect more than 6.8 million people worldwide, and peptic ulcers impact around 10% of the global population at some point in their lives. This shows the demand for effective, and technology-driven diagnostic and treatment solutions.
 

The use of AI in endoscopy is beneficial as it comes with new methods for diagnosis and treatments which make it a prominent factor for market growth. The use of AI technologies increases accuracy, efficiency, and clinical results through AI powered imaging for real-time abnormality detection, automated polyp detection, and predictive analytics for personalized treatment approach. Such innovations ensure that endoscopic processes are more precise and performed rapidly. Also, AI algorithms such as deep learning and computer vision systems are enhancing the sensitivity and specificity of diagnosis, which increases the adoption of these technologies. Moreover, recent developments such as cloud-based analytics platforms and AI-driven remote diagnostic solutions are increasing ease of use and providing healthcare professionals with valuable information.
 

The AI in endoscopy market includes the implementation of artificial intelligence technologies in endoscopic processes in order to increase the accuracy of diagnosis, improve the efficiency of workflows, and achieve better patient outcomes. Such technologies include AI imaging tools, automated diagnostic digital systems, predictive analytic systems, and robotics for gastrointestinal diagnosis and therapeutical procedures.
 

AI in Endoscopy Market Trends

• The growing rate of GI disorders worldwide is responsible for the growth of the market. As stated by the World Gastroenterology Organization (WGO), more than 40% of the world’s population suffers from some type of functional gastrointestinal disorder, indicating a greater need for advanced AI diagnostic tools.
   
• Similarly, colorectal cancer (CRC), which is also the third most common cancer in the world, leading to a higher demand for AI enabled endoscopy. For example, according to the American Cancer Society In 2025, 153,000 new cases of CRC are expected to be diagnosed in the U.S. with approximately 52,550 deaths due to colorectal cancer anticipated in 2025.
   
• Therefore, in recent years, there have been improvements made in artificial intelligence which enable for less intrusive procedures. This has heightened emphasis towards developing accuracy in diagnostics within the gastroenterology and other endoscopic areas.
   
• AI-driven polyp detection and classification systems have been associated with increased adenoma detection rates (ADR), which is helpful in primary diagnosis and treatment. The recent evidence of AI-assisted colonoscopy has shown that polyp detection rates have improved by more than 30%. Therefore, AI technology assists with identifying early mucosal shifts that other methods would miss.
   
• The increasing prevalence of gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD) and Barrett's esophagus increases the need for AI integrated endoscopic systems.
   
• As reported on the National Institutes of Health (NIH), the prevalence of GERD in U.S. ranges between 18.1% to 27.8% with men having slightly higher rates. This indicates a clear need for effective diagnostic measures.
   
• Esophageal cancer cases have increased globally. According to the Word Cancer Research Fund, over 511,054 new cases of esophageal cancer are diagnosed in 2022 globally. AI-based endoscopy systems for early detection help to decrease the mortality of esophageal cancer.
   
• Moreover, the development of new technologies is expected to greatly increase the potential of the market, especially with the introduction of AI tools such as CADe and CADx systems. These systems reduce human error, expedite diagnoses, and optimize workflow and enhance overall productivity. They are very effective in the detection of disease such as chronic obstructive pulmonary disease (COPD) and inflammatory bowel disease (IBD).
   
• Further, several global initiatives promoting AI in medical imaging and diagnostics have boosted market growth. For example, the European Cancer Imaging initiative focuses on AI deployment in endoscopic imaging, ensuring widespread adoption and improved patient outcomes. Simultaneously, spending on AI and healthcare digitization also makes the usage of these technologies more prevalent, which is a contributing factor to the growth of the market.
   

AI in Endoscopy Market Analysis

Based on the type of endoscopy, the market is segmented into gastrointestinal endoscopy, urological endoscopy, respiratory endoscopy, colonoscopy, and other types. The gastrointestinal endoscopy segment dominated the market with USD 407.4 million in 2021, USD 506.7 million in 2022 and USD 631.2 million in 2023.  
 

• The high market size is driven by the growing incidence of colorectal cancer, inflammatory bowel disease, and peptic ulcers. Tools such as CADe enable AI-assisted polyp detection which improves diagnostic accuracy.
   
• Technological advancements such as real-time video analysis and AI-driven image enhancement, streamline workflows and enabling early diagnosis of GI disorders will boost product adoption.
   
• Also, with over 1.9 million new colorectal cancer cases per year and the growing need for less invasive methods of diagnosis and treatment, this segment is poised for fast expansion.
   
• Further, support from the government for the application of AI in healthcare enhances the market growth in this area.

Based on component, the AI in endoscopy market is divided into AI powered devices, software, and services. The AI powered devices segment accounted for a significant market share of 48.7% in 2024.  
 

• The AI powered devices provide improved diagnostic and visualization capabilities, which are vital for endoscopic procedures and accelerate the level of the procedure.
   
• The innovations of AI-based processors, and miniaturized endoscopic tools are helpful in enhancing the detection and diagnosis of gastrointestinal problems. Therefore, the shift towards a preference for real time AI devices and minimally invasive treatments has accelerated the innovation of hardware.
   
• Further, the combination of AI and other techniques in devices has begun providing better results to enable healthcare professionals to get quicker, safer, and more targeted outcomes, thereby augmenting the market growth.
   

Based on type of CAD, the AI in endoscopy market is divided into CADx and CADe. The CADx segment dominated the market in 2024 and is expected to grow with a significant CAGR of 25% over the analysis period.   
 

• CADx or Computer Aided Diagnosis is one of the most advanced segments in market. It aims to improve the diagnostic accuracy of various gastrointestinal disorders such as colorectal cancer, Barrett’s esophagus, and inflammatory bowel disease.
   
• CADx systems improve clinical decision making by processing different endoscopic images with machine learning and deep learning algorithms to classify lesions as either benign or malignant lesions within a small timeframe.
   
• The systems not only process images but also provide probability scores and more refined analysis, unlike the Computer Aided Detection (CADe) system which focuses on the detection of abnormalities. This advancement increases the rates of early detection and lowers the level of dependence on human analysis.
   
• Further, the systems are being developed by several companies such as Fujifilm, Olympus, and Medtronic, who are designing systems integrated with endoscopy. These systems enable earlier stages of disease identification, more reliable decision making, and better overall results.
   
• Therefore, with the expansion of AI systems, CADx is expected to change the face of gastroenterology for the better by improving the quality provided to patients and minimizing unnecessary biopsies.
   

Based on end use, the artificial intelligence in endoscopy market is segmented into hospitals, specialty clinics and other end users. The hospitals segment dominated the market with USD 1.2 billion in 2024 and is expected to reach 11.1 billion by 2034.  
 

• The hospitals segment holds a significant share in the market owing to the growing adoption of new AI technologies for improved diagnosis and patient care.
   
• As first-line providers, hospitals are epicenter in adopting AI tools for real-time detection of abnormalities such as polyps and lesions during endoscopic examinations.
   
• AI-driven automation reduces human error, allows for safer, minimally invasive procedures, and assists in accurate decision making. Also, the increasing prevalence of cancer and gastrointestinal diseases increases the need for improved AI solutions for endoscopy in hospitals.

North America held the largest market share of 44.3% in 2024 in the global AI in endoscopy market, and it is anticipated to expand at a 25.2% CAGR over the forecast period. The U.S. market was valued at USD 471.2 million in 2021. The market size was valued at USD 585.1 million in 2022 and reached USD 727.8 million in 2023.
 

• The U.S. dominates the market due to advanced healthcare infrastructure, high adoption rates of AI technologies, and significant research and development investments. Leading firms along with collaborations between technology companies and hospitals improve product innovation and clinical adoption.
   
• Also, the rising burden of esophageal cancer in U.S. has accelerated demand for AI-integrated endoscopic systems. For example, according to the American Cancer Society, over 20,000 new cases of esophageal cancer are diagnosed in the U.S. annually. In 2025, an estimated 22,370 new cases of esophageal cancer will be diagnosed in the U.S. and approximately 16,130 deaths from esophageal cancer are expected in 2025.
   
• Further, government initiatives supporting digital health will bolster AI integration along with increasing disease burden will spur the country level market growth.
   

Europe AI in endoscopy market accounted for USD 645.6 million in 2024 and is anticipated to show considerable growth over the forecast period.
 

• Europe market is expected to grow significantly due to the stringent regulations regarding early diagnosis of cancer and advancements in AI powered medical imaging.
   
• According to United European Gastroenterology, AI-supported tools can improve adenoma rate detection by almost 25%. This shows the importance of AI supported diagnostic endoscopy in disease diagnosis.
   
• Germany, France, and UK are recently adopting and integrating AI based endoscopic solutions due to the developed healthcare systems and digital health policies from the government.
   
• AI-assisted screening programs are being promoted by leading European gastroenterology societies, especially in the screening for colorectal cancer, which is expected to boost market growth.
   
• Moreover, Germany is also one of the major players in the field of medical AI research, which encourages learning between hospitals and AI startups, as well as physicians and manufacturers of medical devices, to create advanced tools for endoscopic imaging.
   

China AI in endoscopy market is poised to witness high growth over the analysis period.  
 

• The rapid expansion of the market in China is being pushed by governmental efforts in AI and healthcare modernization. The country leverages its vast healthcare data and strong tech ecosystem for developing innovative AI applications.
   
• Also, the growing burden of gastrointestinal diseases, combined with the need for efficient diagnostics in rural and urban areas fuels demand.
   
• Local businesses and startups are working with medical centers to incorporate AI in endoscopy procedures. This improves the availability and accuracy of medical care in the country.
   
• The country is also experiencing rapid adoption of capsule endoscopy along AI-based early cancer detection due to greater awareness along with a rise in the availability of advanced diagnostic tools.
   

The Saudi Arabia AI in endoscopy market is witnessing substantial growth Middle East and Africa.  
 

• The Vision 2030 policy that aims to upgrade healthcare services through modernization and technology integration benefits market in Saudi Arabia. The continuous investments in AI and digital transformation foster new innovations in diagnostics and treatment.
   
• Also, the increasing prevalence of lifestyle associated with gastrointestinal disorders leads to higher demand for sophisticated endoscopic procedures. Continued improvement of the country's healthcare infrastructure ensures increased growth of AI powered medical solutions.
   

AI in Endoscopy Market Share

The top 5 companies in the market account for approximately 70% of the market share, including Medtronic, Olympus, Fujifilm, Hoya, and Intuitive Surgical. These companies focus on AI-powered image enhancement, automated polyp detection, and real-time diagnostic solutions to improve endoscopic procedures. Their innovations enhance workflow efficiency, early disease detection, and physician decision-making in gastroenterology and minimally invasive surgeries. Additionally, several emerging players in the market, such as Iterative Scopes, Odin Vision, and Wision AI, are intensifying competition by offering advanced deep-learning algorithms and cost-effective AI-driven solutions. Companies are leveraging strategic partnerships and acquisitions to expand their presence.
 

AI in Endoscopy Market Companies

Major players operating in the AI in endoscopy industry are:

• Ambu
• Fujifilm
• Hoya
• Intuitive Surgical
• Iterative Scopes
• Magentiq Eye
• Medtronic
• NEC Corporation
• Odin Vision
• Olympus
• PENTAX Medical
• Wision Al
• Wuhan EndoAngel Medical Technology
   

Medtronic offers advanced AI-powered endoscopic solutions designed to enhance real-time lesion detection and classification. Their GI Genius intelligent endoscopy module integrates seamlessly with existing colonoscopy systems, providing automated polyp detection to improve adenoma detection rates and assist gastroenterologists in early colorectal cancer diagnosis.
 

Olympus delivers high-performance endoscopic imaging with its EVIS X1 endoscopy system, which features AI-driven texture and color pattern recognition for improved lesion characterization. This system supports multiple AI-powered tools, including narrow-band imaging (NBI) and computer-aided detection (CAD), enabling precise and real-time diagnostics.
 

Fujifilm specializes in AI-enhanced endoscopy with its CAD EYE technology, designed to assist in polyp detection and characterization during colonoscopy procedures. The system leverages deep-learning algorithms to provide instant visual and auditory alerts, improving physician decision-making and reducing the risk of missed lesions.
 

AI in Endoscopy Industry News

• In April 2024, Medtronic unveiled ColonPRO, the latest software for its GI Genius intelligent endoscopy system, at the Genius Summit 2024. This innovation reinforces Medtronic's leadership in AI-driven endoscopic solutions, advancing patient care in GI diagnostics.
   
• In March 2024, Fujifilm received 510(k) clearance for its AI-powered CAD EYE technology, designed to enhance colonic polyp detection during endoscopy. This innovation highlights Fujifilm's commitment to advancing market with cutting-edge diagnostic solutions.
   
• In July 2023, Magentiq Eye received FDA authorization for its MAGENTIQ-COLO device, an AI-powered solution for colonoscopy. It is one of the few AI tools approved, providing clinicians with insights into the size, type, and maturity of detected lesions, advancing the market.
   

The AI in endoscopy market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type of Endoscopy

• Gastrointestinal endoscopy
• Urological endoscopy
• Respiratory endoscopy
• Colonoscopy
• Other types

Market, By Component

• AI powered devices
• Software
• Services

Market, By Type of CAD

• CADx
• CADe

Market, By End Use

• Hospitals
• Specialty clinics
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands 
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE